173 related articles for article (PubMed ID: 15245739)
1. Immune evasion by gamma-herpesviruses.
Stevenson PG
Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
[TBL] [Abstract][Full Text] [Related]
2. A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.
Kayhan B; Yager EJ; Lanzer K; Cookenham T; Jia Q; Wu TT; Woodland DL; Sun R; Blackman MA
J Immunol; 2007 Dec; 179(12):8392-402. PubMed ID: 18056385
[TBL] [Abstract][Full Text] [Related]
3. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
[TBL] [Abstract][Full Text] [Related]
4. Early establishment of gamma-herpesvirus latency: implications for immune control.
Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
[TBL] [Abstract][Full Text] [Related]
5. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
6. Limited protection against γ-herpesvirus infection by replication-deficient virus particles.
Lawler C; Stevenson PG
J Gen Virol; 2020 Apr; 101(4):420-425. PubMed ID: 31985394
[TBL] [Abstract][Full Text] [Related]
7. Latent antigen vaccination in a model gammaherpesvirus infection.
Usherwood EJ; Ward KA; Blackman MA; Stewart JP; Woodland DL
J Virol; 2001 Sep; 75(17):8283-8. PubMed ID: 11483773
[TBL] [Abstract][Full Text] [Related]
8. Antibody-mediated control of persistent gamma-herpesvirus infection.
Kim IJ; Flaño E; Woodland DL; Blackman MA
J Immunol; 2002 Apr; 168(8):3958-64. PubMed ID: 11937552
[TBL] [Abstract][Full Text] [Related]
9. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
Liu L; Usherwood EJ; Blackman MA; Woodland DL
J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
[TBL] [Abstract][Full Text] [Related]
10. Prospects of a novel vaccination strategy for human gamma-herpesviruses.
Wu TT; Blackman MA; Sun R
Immunol Res; 2010 Dec; 48(1-3):122-46. PubMed ID: 20717741
[TBL] [Abstract][Full Text] [Related]
11. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.
Tibbetts SA; van Dyk LF; Speck SH; Virgin HW
J Virol; 2002 Jul; 76(14):7125-32. PubMed ID: 12072512
[TBL] [Abstract][Full Text] [Related]
12. Gamma interferon blocks gammaherpesvirus reactivation from latency.
Steed AL; Barton ES; Tibbetts SA; Popkin DL; Lutzke ML; Rochford R; Virgin HW
J Virol; 2006 Jan; 80(1):192-200. PubMed ID: 16352543
[TBL] [Abstract][Full Text] [Related]
13. Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant.
Boname JM; Coleman HM; May JS; Stevenson PG
J Gen Virol; 2004 Jan; 85(Pt 1):131-135. PubMed ID: 14718627
[TBL] [Abstract][Full Text] [Related]
14. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.
McClellan JS; Tibbetts SA; Gangappa S; Brett KA; Virgin HW
J Virol; 2004 Jul; 78(13):6836-45. PubMed ID: 15194759
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against murine gamma-herpesvirus infection.
Woodland DL; Usherwood EJ; Liu L; Flaño E; Kim IJ; Blackman MA
Viral Immunol; 2001; 14(3):217-26. PubMed ID: 11572633
[TBL] [Abstract][Full Text] [Related]
16. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
Gangappa S; Kapadia SB; Speck SH; Virgin HW
J Virol; 2002 Nov; 76(22):11460-8. PubMed ID: 12388707
[TBL] [Abstract][Full Text] [Related]
17. Vaccine protection against murid herpesvirus-4 is maintained when the priming virus lacks known latency genes.
Lawler C; Simas JP; Stevenson PG
Immunol Cell Biol; 2020 Jan; 98(1):67-78. PubMed ID: 31630452
[TBL] [Abstract][Full Text] [Related]
18. Immune regulation of viral infection and vice versa.
Virgin HW
Immunol Res; 2005; 32(1-3):293-315. PubMed ID: 16106080
[TBL] [Abstract][Full Text] [Related]
19. Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice.
Flaño E; Kim IJ; Moore J; Woodland DL; Blackman MA
J Immunol; 2003 Apr; 170(7):3828-34. PubMed ID: 12646650
[TBL] [Abstract][Full Text] [Related]
20. LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.
Lange PT; Jondle CN; Darrah EJ; Johnson KE; Tarakanova VL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
